THC · NYSE · Medical - Care Facilities

Tenet Healthcare (THC)

Runs hospitals and a nationwide ambulatory-surgery platform alongside revenue-cycle services.

$263.10
vs last close+2.13 (+0.82%)
Loading prices…

Tenet Healthcare CorporationTHC
Health Care

Runs acute-care and specialty hospitals, outpatient facilities, and Conifer revenue-cycle services, while USPI operates a national ambulatory-surgery platform. Revenue comes from patient care and service contracts, with execution tied to reimbursement, clinical labor, physician relationships, regulation, and healthcare joint ventures.

Operates acute-care and specialty hospitals, physician networks, outpatient facilities, and Conifer revenue-cycle services, primarily for urban and suburban communities in a concentrated group of U.S. states. The hospital business earns from inpatient and outpatient care alongside service contracts.

Owns USPI, a national ambulatory-care platform with interests in hundreds of surgery centers and surgical hospitals across most U.S. states. Growth has increasingly centered on ambulatory surgery while the hospital portfolio has become more concentrated through divestitures.

Execution depends on payer reimbursement, government healthcare programs, managed-care contract terms, clinical labor, physician relationships, and regulated care delivery. USPI also relies on forming and operating joint ventures with physicians and health systems, while Conifer is now fully owned after the CommonSpirit transaction changed its major-client structure.

Company facts

CEOSaum Sutaria, M.D.
ListedMar 17, 1980
ExchangeNYSE
HeadquartersDallas, TX
CountryUnited States
Employees99,000
CIK0000070318
ISINUS88033G4073

Market cap$21.01B
EPS (ttm)$25.93
P/E (ttm)10.06
ROE50.6%
P/B4.51
P/S0.9634
Dividend yieldDiv yield
Beta0.49vs XLV 0.69

Price target$285.00+9.2%Average of 32 analysts
ConsensusBuy26 of 32 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 14, 2026Raymond JamesReiterate
Rating: Target: $270
Rating: OutperformTarget: $285
Aug 10, 2026Mizuho SecuritiesTarget
Target: $225
Target: $290
Aug 3, 2026Wells FargoReiterate
Rating: Target: $231
Rating: OverweightTarget: $281
Jul 28, 2026Goldman SachsReiterate
Rating: Target: $224
Rating: BuyTarget: $305
Jul 28, 2026Truist FinancialTarget
Target: $270
Target: $290

Next report
Oct 27, 26
in 35 days
EPS estimate
$4.67
Revenue estimate
$5.49B
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported$3.44$4.36$4.02$3.70$4.70$4.82$6.12Pending
Estimate$2.95$3.12$2.87$3.34$4.07$4.17$4.26$4.67
Surprise+16.6%+39.7%+40.1%+10.8%+15.5%+15.6%+43.7%

RevenueReportedEstimate

Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported$5.07B$5.22B$5.27B$5.29B$5.53B$5.37B$5.63BPending
Estimate$5.17B$5.14B$5.16B$5.26B$5.47B$5.39B$5.43B$5.49B
Surprise−1.9%+1.6%+2.1%+0.6%+1.0%−0.5%+3.6%
Estimate$4.67
ReportedDue Oct 27, 2026
Estimate$5.49B
ReportedDue Oct 27, 2026
View details

Debt to equity284.40%
Current ratio140.60%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$5.12B$5.07B$5.22B$5.27B$5.29B$5.53B$5.37B$5.63B
Net income$472.0M$318.0M$406.0M$288.0M$342.0M$371.0M$702.0M$826.0M
Net margin9.2%6.3%7.8%5.5%6.5%6.7%13.1%14.7%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$1.09B$821.0M$901.0M$823.0M$889.0M$869.0M$882.0M$1.02B
YoY growth+91.7%+11.7%−72.6%+8.1%−18.4%+5.8%−2.1%+24.4%

Balance sheet, Jun 30, 2026Cash & short-term investments $2.17B · Total debt $13.25B · Total assets $30.68B · Shareholders' equity $4.66B

Revenue
$5.63B
Operating income
$1.02B
Net income
$826.0M
View details

No dividends on record.

Institutions≥ 92.38%74.38M shares
717 holders · as of Jun 30, 2026 · largest filers only
Insiders0.94%757.9K shares
18 holders · as of Sep 16, 2026
Other≤ 6.68%5.38M shares
remainder

80.52M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the 93 largest filers, so at least this.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
BlackRock, Inc.Institution
10.86%8.74Mas of Jun 30, 2026
Price T Rowe Associates Inc /MD/Institution
9.88%7.96Mas of Jun 30, 2026
Boston PartnersInstitution
5.51%4.43Mas of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution
5.26%4.24Mas of Jun 30, 2026
FMR LLCInstitution
4.96%3.99Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Sep 14, 2026J. Robert Kerreydirector−12,010$263.72
Sep 10, 2026Richard J. Markdirector−10,000$263.42
Sep 2, 2026Nadja Westdirector−1,152$258.80
Aug 31, 2026Lisa Y. Fooofficer: EVP, Chief Operating Officer−24,000$266.32
Aug 25, 2026Saumya Sutariadirector, officer: CEO−50,000$274.02
View details

  • HCA Healthcare

    Broad overlap across acute hospitals, outpatient care, and surgery centers

  • Surgery Partners

    Focused rival in short-stay surgery, ASC partnerships, and surgical hospitals

  • UnitedHealth Group

    Major ASC and physician-services overlap through Optum and SCA Health

  • Community Health Systems

    Community-hospital and outpatient overlap across regional delivery systems

  • Universal Health Services

    Acute-care and outpatient rivalry in overlapping U.S. hospital markets

  • Waystar

    Cloud healthcare payments rival to Conifer's revenue-cycle services

Compare

CompanyPriceChange
Tenet Healthcare$263.10+0.82%$21.01B10.112.61.0+6.8%
HCA Healthcare$436.23+2.41%$92.22B14.314.31.2+8.7%
Surgery Partners$15.17+11.02%$1.79B35.30.5+2.8%
UnitedHealth Group$374.45−0.82%$342.88B24.317.50.8+0.4%
Community Health Systems$2.98+3.11%$407.5M0.0−9.8%
Universal Health Services$178.84+2.35%$10.58B7.27.80.6+8.3%
Waystar$25.35−1.40%$4.93B36.714.64.1+18.1%
Median19.314.60.7+5.5%